Prism Capital Partners’ ON3 campus in Nutley and Clifton saw several key projects hit their mid-way point or nearing completion. The tangible progress at the 116-acre redevelopment will be followed this fall by multiple key milestones, including the first corporate occupant and the opening of ON3’s first structured parking.
Prism’s renovation of ON3’s 100 Metro Boulevard – the future home of Ralph Lauren Corporation’s New Jersey hub – is in its final stages. A complete lobby redesign featuring 30-foot ceilings and a new entryway highlights the improvements at the seven-story building.
Outside, Prism has created a courtyard with communal areas for social and business gatherings. Further, the construction of a 2,500-space parking garage to serve both 100 Metro Boulevard and the adjacent, 15-story 200 Metro Boulevard will be finished in time for the iconic American fashion brand’s anticipated October move-in.
At the landmark 200 Metro Boulevard tower, Prism is in the midst of removing the original east-facing marble façade and replacing it with a new curtain-wall glass exterior. This will match the northern and southern facades, and create enhanced views of the Manhattan skyline.
Other renovation work is readying the building for its future tenant(s).
“Ultimately, 100 and 200 Metro Boulevard are key components of the next-generation, mixed-use complex we envision at ON3,” said Prism’s Edwin Cohen, principal partner. “The work being completed at both buildings, and the introduction of the first structure parking in the campus’ history reflect the major steps forward we are taking.”
This work coincides with Quest Diagnostics’ development of a 250,000-square-foot, state-of-the-art diagnostic testing facility at ON3. Steel is up and exterior walls are under construction at that owner-occupied project, which broke ground in March. Additionally, Prism is finalizing plans for a proposed, four-story, 164,000 square-foot speculative laboratory building at ON3 – which would be New Jersey’s first spec lab in recent history. “The expansion of R&D facilities at ON3 signals the region’s continuing rebirth of life sciences and biotech on a site that was once home to healthcare pioneer Hoffmann-La Roche,” Cohen said.